The Empire Discovery Institute – with the University of Rochester, University at Buffalo and Roswell Park Comprehensive Cancer Center as founding partner institutions– will fast track translation of groundbreaking research from the laboratory to commercial opportunity.
Biotech and Life Sciences
Life Science is a Key Driver of Economic Growth
New York’s diversity and strengths are enabling groundbreaking life science innovation
Through strategic investment in biopharmaceutical, device and diagnostic research, development and manufacturing, New York fuels the creation of cutting-edge healthcare solutions. New York is growing its life science industry through a broad range of economic development programs and public-private partnerships, supported by the state’s award-winning research talent. And through its $620 million Life Science Initiative, New York is expanding the state’s ability to commercialize research and spurring the growth of a world-class life science research cluster.
New York’s Wadsworth Center, one of the foremost public health systems in the country, is partnering with world class biopharmaceutical companies to create commercial solutions that address critical public health issues—including Lyme Disease, one of the country’s fastest-growing infectious diseases.
IndieBio New York is a startup development program backed by global venture fund, SOSV, which invests in early-stage life science startups that are tackling the world's most pressing problems in human and planetary health. IndieBio New York promotes innovation by offering companies a dedicated four-month educational program, investment, free lab space, and the opportunity to become part of New York's fast-growing life science ecosystem.
Life Science Initiative: The Next Phase
This strategic plan describes investment opportunities designed to make New York the leading destination for Life Science development.
Life Science Initiative Annual Report: 2023
The Annual Report details the operations and accomplishments of New York State’s Life Science Initiative during 2023.
NYS Biodefense Commercialization Fund
On May 4, 2023, Governor Hochul announced the second round of awardees for the fund, which will fuel disease research, create jobs and encourage continued growth across New York’s expanding life science industry.
Opportunities to grow your business in New York State
Tax-Based Incentives
Operational Support
Growth Support
Innovation Development Support
Industry Contact
For press inquiries, please contact [email protected]